MSH Activators are a diverse set of compounds that facilitate the biological processes initiated by melanocyte-stimulating hormones, particularly through the enhancement of melanogenesis. Forskolin, for instance, raises intracellular cAMP levels, which indirectly boosts MSH's function by increasing PKA activity that phosphorylates MITF, a transcription factor critical for melanin production. Similarly, IBMX and Theophylline prolong the lifespan of cAMP by inhibitingphosphodiesterases, thereby amplifying PKA signaling and, consequently, the melanogenic response of MSH. L-DOPA serves as a direct substrate for tyrosinase, an enzyme whose expression is upregulated by MSH via MITF, thereby providing the necessary components for melanin synthesis. The effectiveness of MSH is further mimicked and enhanced by MSH analogs like Melanotan II, which bind to and activate the melanocortin 1 receptor (MC1R), triggering the same signaling cascade as MSH, leading to increased melanogenesis.
Moreover, anandamide and methoxypsoralen (8-MOP) contribute to the activation of melanogenesis through modulation of cannabinoid receptors and interaction with UVA radiation, respectively, which could synergistically enhance the effects of MSH. The role of copper (II) ions is also crucial as it acts as a cofactor for tyrosinase, and by increasing its availability, the melanogenic effects of MSH are potentiated. Dibutyryl-cAMP, a stable cAMP analog, bypasses receptor-mediated activation and directly stimulates PKA, thus reinforcing the signaling pathways that promote melanogenesis under the influence of MSH. Additionally, while specific inhibitors of the agouti signaling protein (ASP) are not well-characterized, their theoretical use would prevent the antagonism of MSH action at MC1R, thereby boosting MSH's melanogenic activity. Finally, retinoic acid enhances the impact of MSH by upregulating MITF, which leads to an increase in melanin synthesis-related enzymes, ensuring that the biological processes initiated by MSH are carried out more effectively. These activators, through their targeted effects on various biochemical pathways, serve to facilitate the enhancement of MSH-mediated functions, specifically in the realm of pigmentation, without the need for upregulation of its expression or direct activation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels in melanocytes. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate and activate the microphthalmia-associated transcription factor (MITF). MITF upregulates the expression of enzymes critical for melanin production, such as tyrosinase, thus enhancing the melanogenic effect of MSH. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases. By preventing the breakdown of cAMP, IBMX leads to its accumulation within the cell. This, in turn, can potentiate the PKA-mediated phosphorylation of MITF, enhancing the melanogenic response to MSH. | ||||||
Levodopa | 59-92-7 | sc-205372 sc-205372A | 5 g 25 g | $54.00 $171.00 | 9 | |
L-DOPA is a precursor to melanin and a substrate for the enzyme tyrosinase, which is upregulated by MSH via MITF. By providing more substrate for melanin synthesis, L-DOPA can enhance the pigmentation process initiated by MSH. | ||||||
Methoxsalen (8-Methoxypsoralen) | 298-81-7 | sc-200505 | 1 g | $28.00 | 1 | |
Methoxypsoralen, when used in combination with UVA radiation (PUVA therapy), leads to increased melanin synthesis. PUVA-induced melanogenesis might be enhanced by MSH through increased tyrosinase activity. | ||||||
Copper | 7440-50-8 | sc-211129 | 100 g | $51.00 | ||
Copper is a cofactor for tyrosinase, and its presence is essential for the enzymatic activity that leads to melanin production. Enhancing the availability of copper could potentiate the melanogenic effect of MSH. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
This cAMP analog is resistant to degradation by phosphodiesterases. It activates PKA, enhancing the signaling cascade that leads to melanogenesis in the presence of MSH. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline, a phosphodiesterase inhibitor, increases cAMP levels in a similar manner to IBMX, potentially enhancing the melanogenic signaling pathway activated by MSH. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can upregulate MITF, which in turn can increase the expression of melanogenesis-related enzymes. This may enhance the effect of MSH on melanin production. | ||||||